Chloé Apcher

AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network

A. Gingras, Marie-Anne Goyette, R. Daly, 2020, Nature Communications.

Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels

Marie-Anne Goyette, W. Muller, Morag Park, 2021, Proceedings of the National Academy of Sciences.